组蛋白去乙酰化酶3与p53对角质形成细胞水通道蛋白3的调控
本研究探讨组蛋白去乙酰化酶(HDAC)抑制剂对水通道蛋白3(AQP3)的调控机制。在正常角质形成细胞中,广谱HDAC抑制剂SAHA以剂量和时间依赖方式诱导AQP3 mRNA和蛋白表达,并增强甘油摄取;敲低或过表达HDAC3提示其抑制基础AQP3表达,p53参与调控HDAC抑制剂诱导的AQP3表达。
要点
- SAHA可剂量和时间依赖地诱导正常角质形成细胞AQP3表达并增强甘油摄取功能。
- HDAC3在基础状态下抑制AQP3表达,p53参与HDAC抑制剂诱导的AQP3上调。
- SAHA已获批治疗皮肤T细胞淋巴瘤,可能用于AQP3异常表达的银屑病等皮肤病。
核心结论
- HDAC3和p53参与调控角质形成细胞AQP3的表达。
研究设计与样本
- 在正常角质形成细胞及AQP3敲除角质形成细胞中,使用HDAC抑制剂、Cre重组酶介导的HDAC3敲低和过表达进行机制研究。
主要发现
- SAHA以剂量和时间依赖方式诱导正常角质形成细胞AQP3 mRNA和蛋白表达。
- SAHA诱导的AQP3增加使正常角质形成细胞对[3H]甘油摄取增强,但在AQP3敲除细胞中无此增强。
- 使用不同特异性HDAC抑制剂将负责的HDAC成员限定于HDAC1、HDAC2或HDAC3。
- Cre重组酶介导的HDAC3敲低和过表达提示HDAC3在基础状态下抑制AQP3表达。
- p53是参与调控HDAC抑制剂诱导AQP3表达的转录因子。
临床怎么用
- SAHA已获批用于治疗皮肤T细胞淋巴瘤,可能作为AQP3异常表达的银屑病等皮肤病的潜在疗法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aquaporin- (AQP) 3, a water and glycerol channel, plays an important role in epidermal function, with studies showing its involvement in keratinocyte proliferation, differentiation, and migration and in epidermal wound healing and barrier repair. Increasing speculation about the use of histone deacetylase (HDAC) inhibitors to treat skin diseases led us to investigate HDAC's role in the regulation of AQP3. The broad-spectrum HDAC inhibitor suberoylanilide hydroxamic acid induced AQP3 mRNA and protein expression in a dose- and time-dependent manner in normal keratinocytes. The SAHA-induced increase in AQP3 levels resulted in enhanced [3H]glycerol uptake in normal but not in AQP3-knockout keratinocytes, confirming that the expressed AQP3 was functional. Use of HDAC inhibitors with different specificities limited our exploration of the responsible HDAC member to HDAC1, HDAC2, or HDAC3. Cre-recombinase-mediated knockdown and overexpression of HDAC3 suggested a role for HDAC3 in suppressing AQP3 expression basally. Further investigation implicated p53 as a transcription factor involved in regulating HDAC inhibitor-induced AQP3 expression. Thus, our study supports the regulation of AQP3 expression by HDAC3 and p53. Because suberoylanilide hydroxamic acid is already approved to treat cutaneous T-cell lymphoma, it could potentially be used as a therapy for skin diseases like psoriasis, where AQP3 is abnormally expressed.
引用
- Choudhary V, Olala LO, Kagha K, et al. Regulation of the Glycerol Transporter, Aquaporin-3, by Histone Deacetylase-3 and p53 in Keratinocytes. J Invest Dermatol. 2017. PMID: 28526298. doi:10.1016/j.jid.2017.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。